Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini

Overview

Patients with conductive hearing loss fitting the inclusion criteria will be asked to participate in the study. All subjects will be randomized to wear either first the adhesive or the conventional bone conduction hearing aid. They will wear either device for two weeks. They will use the second device for another two weeks. Audiologic tests and quality of life questionnaires will be assessed at the beginning of the study after two weeks with the first device and after two weeks with the second device. Additionally, all patients will be asked to keep a diary including daily wearing time of the device.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: February 18, 2019

Detailed Description

The primary objective of this study is to show, that the ADHEAR will be worn ~75%(~11 to 15 hours per day) of the waking hours, whereas the Contact Mini will be worn ~ 50% (~5 – 8 hours per day) of the waking hours (p<0.05). The authors expect this difference due to increased wearing comfort, reduced/no pressure to the skin of the ADHEAR. The primary objective will be assessed with the diary patients are asked to use. Audiologic testing will consist of free field audiometry, Freiburger monosyllables test and Oldenburg sentence test. All tests will be performed with and without the devices. Quality of life and hearing related questionnaires will consist of the AQoL-8D and the SSQ12.

Interventions

  • Device: Adhear
    • Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks
  • Device: Contact Mini (CM)
    • Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks

Arms, Groups and Cohorts

  • Other: CM-ADHEAR
    • First patients use the Contact Mini (conventional bone conduction device used with a soft band or headband) then ADHEAR (adhesive bone conduction device)
  • Other: ADHEAR – CM
    • First patients use ADHEAR (adhesive bone conduction device) then CM (conventional bone conduction device used with a soft band or headband)

Clinical Trial Outcome Measures

Primary Measures

  • Wearing time
    • Time Frame: 1 year
    • Wearing time per day of the two devices

Participating in This Clinical Trial

Inclusion Criteria

Inclusion criteria

  • Unilateral and/or bilateral conductive hearing loss (CHL) – The bone conduction threshold for the patient's affected ear shall be better than or equal to 25 dB HL (PTA BC for 0.5, 1, 2, 3 kHz). – Subjects aged 13 years or older – Capable of the German language – Willingness and ability to perform all tests required for the study – Signed, and dated informed consent before the start of any study specific procedure Exclusion Criteria:

Exclusion criteria

  • Pregnancy or breastfeeding – Patient is intolerant of the materials as described by Manufacturer's IFU – Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter. – Patient cannot perform the audiological tests or is unable to fill out the questionnaires. – Patient presents with retrocochlear, or central auditory disorder. – any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Gender Eligibility: All

Minimum Age: 13 Years

Maximum Age: 99 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Dominik Riss
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Dominik Riss, Assoc. Prof. PD. Dr. – Medical University of Vienna

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.